The largest database of trusted experimental protocols

Multimode analysis software

Manufactured by Beckman Coulter
Sourced in United States

Multimode Analysis Software is a comprehensive software package that enables the analysis of data from multiple analytical techniques on a single platform. It provides a user-friendly interface for data acquisition, processing, and reporting. The software supports a wide range of detection modes, including absorbance, fluorescence, luminescence, and time-resolved measurements, allowing researchers to conduct diverse experiments and analyses within a single software environment.

Automatically generated - may contain errors

14 protocols using multimode analysis software

1

Proteasome Activity Quantification in Rat Brain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteasome ChTL activity and CL activity were determined by hydrolysis of fluorogenic substrates Suc-LLVY-AMC (Sigma, USA) and Z-LLE-AMC (Tebu-Bio, Belgium), respectively. The activity was determined in portions of 0.5–2 μl of brain extracts in final volume of 100 μl of reaction mix containing 50 mM Na-HEPES, (pH 7.5), 1 mM DTT, and 30 μM Suc-LLVY-AMC or Z-LLE-AMC.
In Supplementary Figure 1, the time dynamics of proteasome ChTL and CL activities in brain extracts of Wistar and August rats obtained with the use of DTX 880 Beckman Coulter and Multimode Analysis Software is presented. On the basis of the results showing the linear dependence of proteasome activities on reaction time, interval of 20 min was chosen for experiments.
So, the reactions were carried out at 37°C for 20 min and terminated by the addition of 1% SDS. The digestion product was detected by using a fluorimeter with the excitation wavelength of 380 nm and the emission wavelength of 440 nm. Proteasome-independent activity was determined in the presence of 5 μM of inhibitor of proteasome activities, Z-leucyl-leucyl-leucinal (MG-132) (Sigma, USA) (less than 10% activity in all samples) and subtracted from the values obtained in the absence of MG-132. In final, proteasome activities were normalized to 1 mg of protein, detected by Lowry method [43 (link)].
+ Open protocol
+ Expand
2

Fluorescence-based PLK1 and PLK3 PBD Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
FLIPs and peptides to be tested were dissolved in DMSO (10 mM) and diluted to working concentrations in assay buffer (a maximum of 600 μM, which equates to a maximum 6% DMSO tolerance determined for the assay). Assays were optimized following standard guidelines (http://www.ncbi.nlm.nih.gov/books/NBK92000/). The PLK1 PBD (367–603) and PLK3 PBD (335–646) proteins were obtained from BPS Bioscience Inc. (San Diego, CA); 41.4 nM PLK1 and 245 nM PLK3 were used per reaction. The fluorescein-tracer phospho-peptides (MAGPMQS[pT]PLNGAKK for PLK1, and GPLATS[pT]PKNG for PLK3) were used at a final concentration of 10 nM. Incubation was carried out at room temperature for 45 min on a shaker. Fluorescence was measured using either a DTX 880 plate reader and Multimode Analysis software (Beckman Coulter, now Molecular Devices, Brea, CA) or a SpectraMax i3 (Molecular Devices, Brea, CA). The polarization values in millipolarization (mP) units were measured at an excitation wavelength of 488 nm and an emission wavelength of 535 nm. Each data point was performed in triplicate for every experiment, and experiments were performed at least three times. An IC50 value for each compound was calculated from non-linear regression analysis of the plots of mP values relative to PBD-tracer mP values alone versus FLIP/peptide concentrations (Supplementary Figures 8, 9).
+ Open protocol
+ Expand
3

Quantitative Tau Protein Aggregation

Check if the same lab product or an alternative is used in the 5 most similar protocols
ThS fluorescence and absorbance were tracked using a DTX 800 plate reader Multimode Detector equipped with a Multimode Analysis Software (Beckman-Coulter, Indianapolis, IN, USA). Filters of 430/35 and 485/20 nm were used for the excitation and emission wavelengths, respectively. 535/25 nm filters were also used for the absorbance determination. It should be stressed that ThS fluorescence normalization was carried out considering as 100% the ThS fluorescence of the bacterial cells expressing tau in the absence of compounds and 0% the ThS fluorescence of the bacterial cells non-expressing tau.
+ Open protocol
+ Expand
4

Cell Viability Assay for Anti-viral Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 96-well white plates 24 h prior as follows: Vero and Caco-2 cells at 5 × 104 cells per well, Calu-3 cells at 1.3 × 105 cells per well. Inhibitors were diluted to the desired micromolar concentration (μM) in the appropriate culture media. Diluted compounds were added to the cells and plates were incubated at 37 °C, 5% CO2. At 24 h post-treatment (hpt), culture media were removed from the cells and cell viability was measured using a CellTiter-Glo® Luminescent Cell Viability Assay per manufacturer’s instructions (Promega, G7572, Madison, WI, USA). Luminescence was measured using a Beckman Coulter DTX 880 Multimode plate reader with Multimode Analysis Software Version 3.3.0.9.
+ Open protocol
+ Expand
5

Trypan Blue and MTT Assays for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trypan blue staining was carried out as described previously [17 (link)] and counted using a Countess™ II Automated Cell Counter (Thermo Fisher). For MTT assays, media from treated cells was replaced with 5 mg/mL 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, #M5655; Millipore-Sigma) solution in base media for 1 h. Cells were washed with PBS, crystals were dissolved using isopropyl alcohol (IPA, 0.5% 1N HCl in isopropanol), and absorbance (λex 570 nm) was measured with a FilterMax F5 microplate reader (Molecular Devices, San Jose, CA, USA) and Multi-Mode Analysis software (Version 3.4.0.27 Beckman Coulter, Brea, CA, USA).
+ Open protocol
+ Expand
6

VEGF-A Quantification in Neuroblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
VEGF-A was measured in neuroblastoma cell culture supernates treated with RG7388 using the human VEGF Quantikine ELISA Kit and recommended protocol (R&D Systems Inc., Minneapolis, MN, USA, Cat DVE00). SH-SY5Y and SK-N-AS neuroblastoma cells were treated with RG7388 (100 nM, 200 nM for 6 h) or untreated in conditions of hypoxia (1% oxygen saturation, 37 °C). Untreated neuroblastoma cells in normoxia were used as a control. Optical density was determined using a 96-well plate reader (DTX 800 multimode detector) at a 450-nm absorbance with 570 nm wavelength subtraction and analyzed with Multimode Analysis Software (Beckman Coulter).
+ Open protocol
+ Expand
7

Fluorescence-based Assay for PLK1 and PLK3 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
ABBAs were dissolved in DMSO (10 mM) and diluted to working in assay buffer to a maximum concentration of 600 mM (maximum of 6% DMSO tolerance in the assay). The PLK1 PBD (367–603) and PLK3 PBD (335–646) proteins were obtained from BPS Bioscience Inc. (San Diego, CA); 17 ng PLK1 and 156 ng PLK3 were used per reaction. The fluorescein-tracer phospho-peptides (MAGPMQS[pT] PLNGAKK for PLK1, and GPLATS[pT]PKNG for PLK3) were used at a final concentration of 10 nM. Incubation was carried out at room temperature for 45 min on a shaker. Fluorescence was measured using a DTX 880 plate reader and Multimode Analysis software (Beckman Coulter, Brea, CA). The polarization values in millipolarization (mP) units were measured at an excitation wavelength of 488 nm and an emission wavelength of 535 nm. Each data point was performed in triplicate for every experiment, and experiments were performed at least three times. IC50 values were calculated from non-linear regression analysis (GraphPad Prism) of the plots of mP values relative to PBD-tracer mP values alone versus PBD-inhibitor concentrations.
+ Open protocol
+ Expand
8

Th-S Fluorescence Assay for Bacterial Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
Th-S (T1892) and other chemical reagents were purchased from Sigma (St. Louis, MO, USA). The Th-S stock solution (2500 mM) was prepared in double-distilled water purified through a Milli-Q system (Millipore, Burlington, MA, USA). Th-S fluorescence and absorbance were tracked using a DTX 800 plate reader Multimode Detector equipped with a Multimode Analysis Software (Beckman-Coulter, Indianapolis, IN, USA). Filters of 430/35 and 485/20 nm were used for the excitation and emission wavelengths, respectively. A filter of 535/25 nm was also used for the absorbance determination. To normalize the Th-S fluorescence as a function of the bacterial concentration, OD600 was obtained using a Shimadzu UV-2401 PC UV–Vis spectrophotometer (Shimadzu, Japan). Note that the fluorescence normalisation was carried out considering 100% of the Th-S fluorescence of the bacterial cells expressing the peptide or protein in the absence of the drug and 0% of the Th-S fluorescence of the bacterial cells not expressing the peptide or protein. A minimum of five independent assays (with three replicates for assay) was performed for each tested compound. More assays were performed to obtain a SEM <5% with a maximum of 10 independent assays.
+ Open protocol
+ Expand
9

Western Blot Analysis of HO-1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze the expression of HO-1, BMMNCs from WT and PLC-β2-deficient mice were harvested, centrifuged, and washed twice with PBS. Protein extracts were then obtained after cell lysis using RIPA lysis buffer supplemented with protease and phosphatase inhibitors (Santa Cruz Biotechnology) and centrifugation at 15,000 rpm at −4 °C for 15 min. The protein concentrations were measured with the Pierce BCA Protein Assay Kit (Pierce, Rockford, IL) and Multimode Analysis Software (Beckman Coulter). Next, adjusted protein lysates (80 μg per sample) were separated on a 4–12 % SDS-PAGE gel, and fractionated proteins were transferred to a PVDF membrane (Bio-Rad). After blocking with 2.5 % non-fat dry milk in Tris-buffered saline containing 0.1 % Tween (TBST) for 1 h at room temperature, then washing with TBST, the membranes were incubated with a rabbit anti-HO-1 polyclonal antibody (Enzo Life Sciences, NY, USA, diluted 1:1000) overnight at 4 °C. Equal loading of proteins in all lanes was assured by reprobing with rabbit anti-β-actin monoclonal antibody (Novus Biologicals, USA, diluted 1:1000). Enhanced chemiluminescence (ECL) reagent (Amersham Life Sciences) and film (Hyperfilm, Amersham Life Sciences) were used for band visualization [19 (link), 21 (link)].
+ Open protocol
+ Expand
10

Neuroblastoma Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferation was evaluated in NGP, SH-SY5Y, LAN-5, LAN-5 si-p53, and SK-N-AS neuroblastoma cells treated with RG7388 using the CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega, Madison, WI, USA, Cat G3582). Briefly, 3000 cells per well were plated into a 96-well microtiter plate and incubated at 37 °C overnight. Next day, the media were replaced with 100 μl of fresh media, untreated or treated with RG7388 (5.86 nM–1.5 μM titration). Following a 72-h incubation, 20 μl of One Solution Reagent (MTS and phenazine ethosulfate) was added to each well, and the plate was further incubated for 4 h in the dark at 37 °C. Optical density was determined using a 96-well plate reader (DTX 800 multimode detector) at a 490-nm absorbance and analyzed with Multimode Analysis Software (Beckman Coulter, Brea, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!